NEOGENOMICS INC (NEO) is a publicly traded company in the Unknown sector. Across all available filings, 48 corporate insiders have executed 574 transactions totaling $378.3M, demonstrating a bearish sentiment with -$375.0M in net insider flow. The most recent transaction on Jan 20, 2026 involved a sale of 22,128 shares valued at $276.7K.
No significant insider buying has been recorded for NEO in the recent period.
No significant insider selling has been recorded for NEO in the recent period.
Based on recent SEC filings, insider sentiment for NEO is bearish with an Insider Alignment Score of 0/100 and a net flow of -$375.0M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at NEOGENOMICS INC (NEO) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 48 insiders are actively trading NEO stock, having executed 574 transactions in the past 90 days. The most active insider is Medical Systems Information Technologies, Inc. Ge (Executive), who has made 1 transactions totaling $130.0M.
Get notified when executives and directors at NEO file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jan 20, 2026 | Stone Warren | Pres & Chief Operating Officer | Sale | 22,128 | $12.50 | $276.7K | C-Suite |
| Jan 13, 2026 | C. Olivo Alicia | EVP, GC & Business Development | Payment | 15,145 | $N/A | $0 | |
| Jan 13, 2026 | C. Olivo Alicia | EVP, GC & Business Development | Option Exercise | 59,382 | $N/A | $0 | |
| Jan 13, 2026 | Stone Warren | Pres & Chief Operating Officer | Payment | 15,127 | $N/A | $0 | C-Suite |
| Jan 13, 2026 | Stone Warren | Pres & Chief Operating Officer | Option Exercise | 59,382 | $N/A | $0 | C-Suite |
| Dec 7, 2025 | Scott Sherman Jeffrey | Executive | Payment | 11,938 | $N/A | $0 | |
| Dec 1, 2025 | Stone Warren | Executive | Payment | 8,776 | $N/A | $0 | |
| Nov 25, 2025 | C. Olivo Alicia | Executive | Option Exercise | 8,977 | $10.05 | $90.2K | |
| Nov 25, 2025 | C. Olivo Alicia | Executive | Sale | 20,916 | $12.00 | $251.0K | |
| Oct 16, 2025 | C. Olivo Alicia | Executive | Sale | 4,918 | $10.00 | $49.2K | |
| Sep 1, 2025 | C. Olivo Alicia | Executive | Payment | 1,666 | $N/A | $0 | |
| Aug 6, 2025 | P. Zook Anthony | Executive | Purchase | 17,900 | $5.58 | $99.9K | |
| Aug 6, 2025 | Scott Sherman Jeffrey | Executive | Purchase | 20,000 | $5.62 | $112.4K | |
| Aug 1, 2025 | C. Olivo Alicia | Executive | Payment | 14 | $N/A | $0 | |
| Sep 1, 2024 | C. Olivo Alicia | Executive | Payment | 1,666 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 180 | $376.7M | 90.5% |
Exercise(M) | 160 | $31.7M | 7.6% |
Payment(F) | 66 | $2.3M | 0.6% |
Gift(G) | 19 | $2.3M | 0.5% |
Purchase(P) | 13 | $1.7M | 0.4% |
Award(A) | 127 | $1.2M | 0.3% |
Disposition(D) | 2 | $268.4K | 0.1% |
Exercise (Options)(X) | 2 | $62.6K | 0.0% |
Small Acquisition(L) | 3 | $19.9K | 0.0% |
Other(J) | 2 | $0 | 0.0% |
Insider selling pressure at NEOGENOMICS INC has increased, with 48 insiders executing 574 transactions across all time. Total sales of $376.7M significantly outpace purchases of $1.7M, resulting in a net outflow of $375.0M. This selling activity appears largely discretionary, which may warrant closer attention from investors.